138 related articles for article (PubMed ID: 2737547)
1. Measurement of CEA, TPA, neopterin, CA125, CA153 and CA199 in sera of pregnant women, umbilical cord blood and amniotic fluid.
Lellé RJ; Henkel E; Leinemann D; Goeschen K
Gynecol Obstet Invest; 1989; 27(3):137-42. PubMed ID: 2737547
[TBL] [Abstract][Full Text] [Related]
2. Immunoradiometrical measurement of tissue polypeptide antigen (TPA) and cancer antigen 125 (CA125) in pregnancy and at delivery.
Itahashi K; Inaba N; Fukazawa I; Takamizawa H
Arch Gynecol Obstet; 1988; 243(4):191-7. PubMed ID: 3223775
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic value of determination of CEA, CA125, CA153 and CA199 assay in pleural fluid for lung cancer].
Wu G; Ba J; Wang E; Teng Y; Fan X
Zhongguo Fei Ai Za Zhi; 2004 Feb; 7(1):35-7. PubMed ID: 21211189
[TBL] [Abstract][Full Text] [Related]
4. Measurement of Tennessee antigen, carcinoembryonic antigen, tissue polypeptide antigen and alpha-feto-protein in body fluids associated with pregnancy.
Oehr P; Bellmann O; Hamann D
Clin Biochem; 1982 Feb; 15(1):13-6. PubMed ID: 6175441
[TBL] [Abstract][Full Text] [Related]
5. CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause.
Wang XF; Wu YH; Wang MS; Wang YS
Asian Pac J Cancer Prev; 2014; 15(1):363-8. PubMed ID: 24528057
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of seven different tumour markers for the establishment of tumour marker panels in gynecologic malignancies.
Avall Lundqvist E; Nordström L; Sjövall K; Eneroth P
Eur J Gynaecol Oncol; 1989; 10(6):395-405. PubMed ID: 2627971
[TBL] [Abstract][Full Text] [Related]
7. Expression of CEA, CA-125 and SCC antigen by biological fluids associated with pregnancy.
Sarandakou A; Kontoravdis A; Kontogeorgi Z; Rizos D; Phocas I
Eur J Obstet Gynecol Reprod Biol; 1992 May; 44(3):215-20. PubMed ID: 1607061
[TBL] [Abstract][Full Text] [Related]
8. Experiments with tissue cultures from a human ovarian serous cystadenocarcinoma producing cancer antigen 125 (CA125), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA).
Fukazawa I; Inaba N; Ota Y; Sato N; Shirotake S; Iwasawa H; Sekiya S; Takamizawa H; Suzuki N; Tokita H
Arch Gynecol Obstet; 1988; 243(2):69-81. PubMed ID: 3165255
[TBL] [Abstract][Full Text] [Related]
9. Clinical Value of Tumor Markers for Determining Cause of Pleural Effusion.
Gu Y; Zhai K; Shi HZ
Chin Med J (Engl); 2016 Feb; 129(3):253-8. PubMed ID: 26831224
[TBL] [Abstract][Full Text] [Related]
10. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases.
Nicolini A; Tartarelli G; Carpi A; Metelli MR; Ferrari P; Anselmi L; Conte M; Berti P; Miccoli P
BMC Cancer; 2006 Nov; 6():269. PubMed ID: 17116247
[TBL] [Abstract][Full Text] [Related]
11. Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients.
Chen Y; Gao SG; Chen JM; Wang GP; Wang ZF; Zhou B; Jin CH; Yang YT; Feng XS
Cell Biochem Biophys; 2015 Apr; 71(3):1287-91. PubMed ID: 25486903
[TBL] [Abstract][Full Text] [Related]
12. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].
Kataoka A; Yakushiji M
Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):47-54. PubMed ID: 2157782
[TBL] [Abstract][Full Text] [Related]
13. Neopterin. A tumor marker in colorectal carcinoma?
Putzki H; Aschern F; Henkel E; Heymann H
Dis Colon Rectum; 1987 Nov; 30(11):879-83. PubMed ID: 3479311
[TBL] [Abstract][Full Text] [Related]
14. Tumor markers in hypertensive disorders of pregnancy.
Schröcksnadel H; Daxenbichler G; Artner E; Steckel-Berger G; Dapunt O
Gynecol Obstet Invest; 1993; 35(4):204-8. PubMed ID: 7687229
[TBL] [Abstract][Full Text] [Related]
15. Combination assay of CA125, TPA, IAP, CEA, and ferritin in serum for ovarian cancer.
Yabushita H; Masuda T; Ogawa A; Noguchi M; Ishihara M
Gynecol Oncol; 1988 Jan; 29(1):66-75. PubMed ID: 3422208
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic usefulness of stepwise discriminant analysis employing the values of CA125, TPA, IAP, CEA and ferritin in sera measured simultaneously for gynecological malignant neoplasms].
Yabushita H; Masuda T; Hattori A; Noguchi M; Ito Y; Nakanishi M; Ishihara M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1883-92. PubMed ID: 2997349
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic value of multiple tumor marker detection for mature and immature teratoma of the ovary].
Chen C; Li JD; Huang H; Feng YL; Wang LH; Chen L
Ai Zheng; 2008 Jan; 27(1):92-5. PubMed ID: 18184473
[TBL] [Abstract][Full Text] [Related]
18. [Changes in serum levels of gynecological tumor markers throughout the period from early gestation to puerperium].
Sugawara T; Tanaka T; Sato H; Hanatani K; Okuyama K; Shinkai N; Sakuragi N; Makinoda S; Fujimoto S
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Feb; 43(2):145-51. PubMed ID: 1707431
[TBL] [Abstract][Full Text] [Related]
19. [A preliminary study of retinoblastoma-related serum tumor markers].
Liu ZP; Zhou KY; Chen LL; Xiao ZH; Chen YZ
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Mar; 19(3):318-321. PubMed ID: 28302204
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer.
Shan D; Cheng S; Ma Y; Peng H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jul; 48(7):1039-1049. PubMed ID: 37724407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]